ReviewAdvances in pharmacology (San Diego, Calif.)2012

Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations.

Rajasekharan Somasundaram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.